<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00866567</url>
  </required_header>
  <id_info>
    <org_study_id>MatPed 08-017</org_study_id>
    <nct_id>NCT00866567</nct_id>
  </id_info>
  <brief_title>Defects in Opsonophagocytosis in Premature Infants</brief_title>
  <official_title>Defects in Opsonophagocytosis in Premature Infants as a Factor for the Development of Neonatal Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gertrud von Meissner Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Society of Intensive Care Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swiss National Fund for Scientific Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to characterize innate immune function of premature infants, and
      identify defects that may be responsible for the development of bacterial sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sepsis is an important problem in preterm infants and carries a significant morbidity and
      mortality. It is estimated that 20% of premature infants surviving beyond the first three
      days of life will have one or more culture-proven bacteremic sepsis. There is increasing
      epidemiologic and biologic evidence suggesting that preterm newborns are more susceptible to
      infection than term newborns and adults. Immaturity of the immune system, and, in particular,
      defects in innate responses to pathogens are of foremost importance in the pathogenesis of
      neonatal sepsis. The aims of the study are the:

        1. Determination of the opsonic capacity of plasma from premature infants, vs. term
           newborns, and identification possible molecular innate immune defect(s) in preterm
           plasma.

        2. Characterization of the role of TLR2 and TLR4 responses in phagocytes from premature
           infants using classical TLRs agonists. Determination of the capacity of plasma from
           premature infants to sustain TLR pathways, with a particular attention paid to the
           possible role of soluble MD-2 in plasma from premature infants in TLR-dependent
           opsonophagocytosis.

        3. Determine prognostic factors for neonatal sepsis. The identification of a quantitative
           and/or qualitative defect in innate plasma protein(s) in premature newborns has the
           potential of identifying those infants who are likely to develop a neonatal sepsis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Leukocyte phenotype, opsonophagocytic function, and whole blood response to pathogens</measure>
    <time_frame>at delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leukocyte phenotype, opsonophagocytic function during neonatal sepsis</measure>
    <time_frame>1 week after recruitment</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Prematurity</condition>
  <condition>Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Premature infants of less than 28 weeks of gestational age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Premature infants of more than 28 weeks and less than 32 weeks of gestational age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Term newborns</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Adults</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum cDNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All premature infants delivered at the University Hospitals of Geneva
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premature or term delivery

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerome PUGIN, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospitals of Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel BERNER, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospitals of Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre TISSIERES, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals of Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals of Geneva</name>
      <address>
        <city>Geneva</city>
        <state>Geneva 14</state>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2009</study_first_submitted>
  <study_first_submitted_qc>March 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2009</study_first_posted>
  <last_update_submitted>February 2, 2010</last_update_submitted>
  <last_update_submitted_qc>February 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2010</last_update_posted>
  <responsible_party>
    <name_title>Pierre TISSIERES, MD; MSc</name_title>
    <organization>University Hospital, Geneva</organization>
  </responsible_party>
  <keyword>prematurity</keyword>
  <keyword>VLBW</keyword>
  <keyword>sepsis</keyword>
  <keyword>innate immunity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

